Abstract 2050P
Background
Anorexia is the fourth common symptom seen in half of newly diagnosed cancer patients. It also remains most prevalent and troublesome clinical problem experienced by patients with cancer during and after chemotherapy. Consequently, anorexia adversely influences nutritional status of a patient which further causes a negative impact on quality of life and survival. Various herbs have shown to be having positive effect on treating anorexia. In this study, we analysed the effect of an Ayurveda formulation consisting standardised dry powders of 5 herbs indicated in Ayurveda for treatment of Anorexia.
Methods
We did an assessment of study variables related to anorexia, cachexia and quality of life in a heterogeneous group of stage IV cancer patients (n=45) receiving conventional therapies for cancer and complaining of anorexia. These patients were administered herbal capsule “Ruchir” for treatment of Anorexia. Ruchir is consisting dry herbal powders of Pomegranate (Punica grantum), Black pepper (Piper nigrum), Ginger (Zingiber officinale), Amla (Phyllanthus emblica), Cumin (Cuminum cyminum). Therapy response on Anorexia was assessed using AC (Anorexia/cachexia subscale) and its impact on quality of life was assessed using Functional Assessment of Anorexia / Cachexia Treatment (FAACT). Weight was recorded at each visit (day 0, day 30, day 90, and day 180) using digital weighing scale. Statistical significance was assessed using nonparametric Wilcoxon Signed Ranks Test.
Results
The mean age of study participants were 64.54 (±5.6) years. Significant improvement was observed in Anorexia sub scale score (P < 0.01) and quality of life (P<0.05) as compared to baseline. No significant change was observed in weight. Treatment was well tolerated by all patients.
Conclusions
Herbs used in this study have been shown to have significant effects in reducing anorexia and improving quality of life in a heterogeneous group of cancer patients. This study provides preliminary evidence about effectiveness of herbs in treating Anorexia in cancer patients. Further controlled studies in a homogenous group of patients are warranted to integrate herbs with a standard of care in cancer patients for management of Anorexia.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
Y.N. Bendale: Other, Personal, Ownership Interest: Rasayu Cancer Clinic. All other authors have declared no conflicts of interest.
Resources from the same session
2106P - Safety and patient reported outcomes of SARS-CoV-2 vaccination in patients with cancer
Presenter: Amy Body
Session: Poster session 06
2107P - Thromboprophylaxis with intermediate or prophylactic doses of LMWHs in ambulatory cancer patients
Presenter: Nikolaos Tsoukalas
Session: Poster session 06
2108P - Vitamin B12 and its clinical relevance in hospitalized cancer patients
Presenter: Stefano Maccarone
Session: Poster session 06
2109P - Vitamin A, D and E levels in patients with solid tumors undergoing palliative systemic cancer treatment
Presenter: Julia Berger
Session: Poster session 06
2111P - The value of multiple psychometric tools for distress screening and referral in a cancer population
Presenter: Daniel Anderson
Session: Poster session 06
2112P - Initial geriatric assessment and chemotherapy tolerability treatment in Brazilian patients with malignant neoplasm of the digestive system
Presenter: Marcos Dumont Bonfin Santos
Session: Poster session 06
2113P - Efficacy and effectiveness of prophylactic magnesium supplementation on prevention of cisplatin-induced nephrotoxicity: A systematic review and meta-analysis
Presenter: Caio Castro
Session: Poster session 06
2114P - Impact of comprehensive geriatric assessment (CGA) in the management of chemotherapy toxicity in older cancer patients
Presenter: Jordi Recuero-Borau
Session: Poster session 06
2115P - Pre-cachexia incidence in patients with solid cancer: A cross-sectional study
Presenter: Lynn Gottmann
Session: Poster session 06